BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35014411)

  • 41. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
    Lale SV; R G A; Aravind A; Kumar DS; Koul V
    Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth.
    Zhang D; Xu Q; Wang N; Yang Y; Liu J; Yu G; Yang X; Xu H; Wang H
    Int J Nanomedicine; 2018; 13():4549-4561. PubMed ID: 30127606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of cellular uptake and antitumor efficiencies of micelles with phosphorylcholine.
    Tu S; Chen YW; Qiu YB; Zhu K; Luo XL
    Macromol Biosci; 2011 Oct; 11(10):1416-25. PubMed ID: 21793214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-delivery of hydrophilic and hydrophobic drugs by micelles: a new approach using drug conjugated PEG-PCLNanoparticles.
    Danafar H; Rostamizadeh K; Davaran S; Hamidi M
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1908-1918. PubMed ID: 28737462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
    Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
    Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphorylcholine zwitterionic shell-detachable mixed micelles for enhanced cancerous cellular uptakes and increased DOX release.
    Cao H; Lu Q; Wei H; Zhang S
    J Mater Chem B; 2022 Jul; 10(29):5624-5632. PubMed ID: 35815797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery.
    Shuai X; Ai H; Nasongkla N; Kim S; Gao J
    J Control Release; 2004 Aug; 98(3):415-26. PubMed ID: 15312997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs.
    Liu SQ; Wiradharma N; Gao SJ; Tong YW; Yang YY
    Biomaterials; 2007 Mar; 28(7):1423-33. PubMed ID: 17141308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery.
    Mahmud A; Xiong XB; Lavasanifar A
    Eur J Pharm Biopharm; 2008 Aug; 69(3):923-34. PubMed ID: 18430550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis, characterization, and property of biodegradable PEG-PCL-PLA terpolymers with miktoarm star and triblock architectures as drug carriers.
    Zhang Y; Luo S; Liang Y; Zhang H; Peng X; He B; Li S
    J Biomater Appl; 2018 Mar; 32(8):1139-1152. PubMed ID: 29298551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improving anticancer activity and reducing systemic toxicity of doxorubicin by self-assembled polymeric micelles.
    Gou M; Shi H; Guo G; Men K; Zhang J; Zheng L; Li Z; Luo F; Qian Z; Zhao X; Wei Y
    Nanotechnology; 2011 Mar; 22(9):095102. PubMed ID: 21270494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
    Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
    Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and colloidal characterization of folic acid-modified PEG-b-PCL Micelles for methotrexate delivery.
    Brandt JV; Piazza RD; Dos Santos CC; Vega-Chacón J; Amantéa BE; Pinto GC; Magnani M; Piva HL; Tedesco AC; Primo FL; Jafelicci M; Marques RFC
    Colloids Surf B Biointerfaces; 2019 May; 177():228-234. PubMed ID: 30753959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
    Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
    Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Zwitterionic Phosphorylcholine-TPE Conjugate for pH-Responsive Drug Delivery and AIE Active Imaging.
    Chen Y; Han H; Tong H; Chen T; Wang H; Ji J; Jin Q
    ACS Appl Mater Interfaces; 2016 Aug; 8(33):21185-92. PubMed ID: 27482632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation of core cross-linked PCL-PEG-PCL micelles for doxorubicin delivery in vitro.
    Zhang J; Men K; Gu Y; Wang X; Gou M; Guo G; Luo F; Qian Z
    J Nanosci Nanotechnol; 2011 Jun; 11(6):5054-61. PubMed ID: 21770143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multi-stimuli-responsive nanomicelles fabricated using synthetic polymer polylysine conjugates for tumor microenvironment dependent drug delivery.
    Augustine R; Kim DK; Kalva N; Eom KH; Kim JH; Kim I
    J Mater Chem B; 2020 Jul; 8(26):5745-5755. PubMed ID: 32519736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
    Shen Z; Li Y; Kohama K; Oneill B; Bi J
    Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymeric micelles with citraconic amide as pH-sensitive bond in backbone for anticancer drug delivery.
    Cao J; Su T; Zhang L; Liu R; Wang G; He B; Gu Z
    Int J Pharm; 2014 Aug; 471(1-2):28-36. PubMed ID: 24836667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
    Lee ES; Na K; Bae YH
    J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.